Exclusive-McKinsey nears deferred prosecution pact in US opioid probe, sources say

McKinsey & Co is close to reaching a $600 million settlement with the U.S. Department of Justice to resolve a criminal investigation into its role in aiding opioid manufacturers. This agreement would involve a deferred prosecution deal with terms yet to be finalized.